Skip to main content

View full-text article in PMC

. 2023 Mar 6;13(3):e12229. doi: 10.1002/clt2.12229

TABLE 3.

Correlations between the levels of LTE₄ and EDN in patients with AERD or ATA.

	Asthma (n = 136)			AERD (n = 47)			ATA (n = 89)
	Sputum EDN	Urine EDN	Plasma EDN	Sputum EDN	Urine EDN	Plasma EDN	Sputum EDN	Urine EDN	Plasma EDN
Serum LTE₄	p = 0.011	p = 0.160	p = 0.008	p = 0.003	p = 0.368	p = 0.017	p = 0.505	p = 0.576	p = 0.419
Serum LTE₄	r = 0.347	p = 0.160	r = 0.226	r = 0.605	p = 0.368	r = 0.348	p = 0.505	p = 0.576	p = 0.419
Urine LTE₄	p = 0.023	p < 0.001	p < 0.001	p = 0.218	p = 0.013	p = 0.002	p = 0.303	p = 0.039	p = 0.001
Urine LTE₄	r = 0.311	r = 0.362	r = 0.388	p = 0.218	r = 0.369	r = 0.445	p = 0.303	r = 0.228	r = 0.334

Abbreviations: AERD, aspirin‐exacerbated respiratory disease; ATA, aspirin tolerant asthma; EDN, eosinophil‐derived neurotoxin; LT, leukotriene.